Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Company
Novartis Jiangsu API base put into operation2009-12-11
Baiyunshan and DSM signed Cefalexin API supply agreement2009-12-09
Vitamin C output capacity of Shandong Luwei reached 30000ton2009-12-08
Tiger Biotech to expand vitamin C capacity2009-12-04
Weisheng's vitamin C granules passed Sweden examination2009-12-04
Simcere acquires production approval for Rosuvastatin Calcium2009-11-30
Pfizer to build R&D facility in China2009-11-27
Zenith Chemical plans to found Vimtamin C project in Heihe2009-11-26
Zhebang to found Cefaclor and Cefalexin project2009-11-26
Hisun had founded branch in USA2009-11-25
Zhejiang XinHua and Pfizer started the cooperation of penicillins2009-11-25
Supply short, NCPC increased Ampicillin sodium output2009-11-24
Merck Serono to build research centre in Beijing2009-11-24
Fangtong is building new base of intermediates of steroid drugs2009-11-23
Taizhou Erkang to produce Valsartan, Olmesartan and Ezetimibe2009-11-20
Yongning did technological improvement of Cephalosporins2009-11-20
Sinovac gets approval to distribute swine flu vaccine in Mexico2009-11-19
Livzon Synthetic to produce Ceftriaxone sodium and Cefuroxime sodium2009-11-19
Hebei Union Pharma to built APIs project2009-11-18
Hisun contracted with Schering-Plough to produce premix drugs for animal use2009-11-18
Weisheng resumes Vitamin C production late October2009-11-17
NCPC to expand cephalosporins production capacity2009-11-13
United Laboratories's Ampicillin passed FDA authentication2009-11-13
Pfizer and BMP Sunstone to collaborate on endometriosis drug2009-11-12
Taiwan ScinoPharm founds subsidiary in Changshu2009-11-10
HuaHai's Losartan Potassium and Valsartan projects won support funds2009-11-06
Honest Chem began the pilot production of Lipoic Acid2009-11-04
Luliang's Vitamin K3 export value sharply increases2009-11-02
NCPC new industry park started construction2009-10-30
GuoBang got COS certificate for its Clarithromycin2009-10-29
Guangji founds join venture to produce Vit. B62009-10-28
Novartis aiming to expand OTC Business in China2009-10-27
共2619个 页次:74/82页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463